Home | All secondary_outcomes

[RDF data]
Secondary Outcomes #100403

Resource URI: http://static.linkedct.org/resource/secondary_outcomes/100403
rdfs:label Secondary Outcomes #100403
linkedct:measure Safety and feasibility: Within the first 8 patients in the two-stage phase II design, an assessment of safety (less than 33% dose limiting toxicities) and feasibility (adequate cell therapy manufacture) will be made.
linkedct:safety_issue Yes
is linkedct:secondary_outcomes of <http://static.linkedct.org/resource/trials/NCT00910650>
linkedct:secondary_outcomes_id 100403 (xsd:int)
linkedct:time_frame 3 months
rdf:type linkedct:secondary_outcomes